BriefTea
Every story in sixty words
Health · 9 hours ago
Surrey NHS trust is the first in Europe to take part in the global trial for a new drug called Trontinemab. Researchers hope Trontinemab can delay or even stop Alzheimer's, which causes up to 80% of dementia cases. The drug targets a sticky protein that accumulates between brain cells, and 1,600 healthy adults between 55 and 80 years old are being recruited internationally.
Reported by BBC · How we write briefs
Understand this story
Why trial new drugs?More briefs
HealthNHS begins testing a new Alzheimer's drug on adults without memory problems HealthNHS changes pharmacy blood pressure checks to once every five years HealthNew map shows England's most depressed areas HealthGran warns against Facebook dentures that look like Haribo sweets HealthSix-year-old Max Kuc dies after falling ill at football match HealthRussell Howard and wife Cerys Morgan's baby Felix died shortly after birth More health stories → Browse all stories →